Sustainable value creation in the commercialisation of innovation: the case of Auria Biobank
Self archived versionfinal draft
MetadataShow full item record
CitationLehtimäki, Hanna. Helén, Ilpo. Snell, Karoliina. Eriksson, Päivi. Montonen, Tero. (2019). Sustainable value creation in the commercialisation of innovation: the case of Auria Biobank. International journal of entrepreneurship and innovation management, 23 (5) , 451-465. 10.1504/IJEIM.2019.10022405.
The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.